E-ISSN: 2822-2741
Contact
|
Home
Aims & Scope
Editorial Board
Instructions for Authors
Ethics & Policies
Contact
Volume: 3 Issue: 3 Year: 2024
Current Issue
Ahead of Print
Archive
Most Accessed Articles
Copyright Form
Author Contribution Form
ICMJE COI Form
Submit
an Article
Join
E-mail List
In titles
In abstracts
In keywords
In authors
Ahead Of Print
1.
Impact of Extraintestinal Manifestations on Inflammatory Bowel Disease Treatment
Pelin Telli
,
Murat Törüner
DOI:
10.14744/Jenterocolitis.2025.60611
Abstract
2.
Differential Diagnosis of Inflammatory Bowel Disease
Oğuz Kağan Bakkaloğlu
,
Aykut Ferhat Çelik
DOI:
10.14744/Jenterocolitis.2025.82883
Abstract
3.
Epidemiology of Inflammatory Bowel Disease
Güner Kılıç
,
Mehmet Arhan
DOI:
10.14744/Jenterocolitis.2025.25095
Abstract
4.
Clinical Status and Extra-Intestinal Findings of Inflammatory Bowel Disease
Güner Kılıç
,
Mehmet Arhan
DOI:
10.14744/Jenterocolitis.2025.72759
Abstract
5.
Diagnostic Approach in Inflammatory Bowel Diseases
Gizem Dağcı
,
Filiz Akyüz
DOI:
10.14744/Jenterocolitis.2025.02124
Abstract
6.
Drug-Related Adverse Events in Inflammatory Bowel Disease
Tugce Eskazan
,
Ibrahim Hatemi
DOI:
10.14744/Jenterocolitis.2025.98900
Abstract
7.
Evaluation of Patients with Inflammatory Bowel Disease of Childbearing Age
Idris Kurt
,
Hüseyin Ahmet Tezel
DOI:
10.14744/Jenterocolitis.2025.67822
Abstract
8.
Treatment of Crohn's Disease: Induction of Remission, Maintenance, and Management of Remission Period: A Comprehensive Review
Pelin Telli
,
Murat Törüner
DOI:
10.14744/Jenterocolitis.2025.45294
Abstract
9.
Clinical and Endoscopic Classification and Activity Indices of Inflammatory Bowel Diseases
Hüseyin Ahmet Tezel
,
Idris Kurt
DOI:
10.14744/Jenterocolitis.2025.03924
Abstract
10.
Surgical Treatment in Inflammatory Bowel Disease
Tugce Eskazan
,
Ibrahim Hatemi
DOI:
10.14744/Jenterocolitis.2025.39728
Abstract
11.
Ustekinumab as Salvage Therapy in a Patient with Acute Severe Ulcerative Colitis
Özge Coşkun
,
Yeşim Özen Alahdab
,
Özlen Atuğ
,
Haluk Tarık Kani
DOI:
10.14744/Jenterocolitis.2025.00529
Abstract
12.
COVID-19 Seroprevalence and Risk Factors in Inflammatory Bowel Disease Patients Receiving Immunosuppressive Treatment in the Pre-Vaccine Era
Tuğçe Eşkazan
,
Gökhan Aygün
,
Oğuz Kağan Bakkaloğlu
,
Enes Ali Kurt
,
Okan Kadir Nohut
,
Selçuk Candan
,
Uğur Önal
,
Yusuf Erzin
,
Ali İbrahim Hatemi
,
Aykut Ferhat ÇeliK
DOI:
10.14744/Jenterocolitis.2025.99310
Abstract
Close
Submit